Nottingham, United Kingdom, December 06, 2011 --(PR.com
)-- Slimming and weight management products remain one of the most popular food supplement categories in the EU but an EFSA review of the numerous active ingredients, which claimed to provide a means of weight loss, have all been negative. The new Chrysalis formulations meet recommendations suggested by EFSA to enable claims such as:
"Glucomannan contributes to the reduction of body weight in the context of an energy restricted diet."
"Regular consumption of Glucomannan helps maintain normal blood cholesterol concentrations."
Sales Director Mark Broughton commented, “EFSA’s review of proposed claims for slimming ingredients has resulted in negative opinion across the board, this means innovation in this category is extremely challenging, our new products meet EFSA recommendations and allow for strong and clear weight management claims on pack and more importantly effective and clearly labelled products for consumers.”
The new slimming range is being made available for private label clients in the UK and Europe, further details are available from the Chrysalis website or by contacting email@example.com
About Chrysalis Health & Beauty
Chrysalis is a UK based health and Personal Care business, which offers specialist formulation, development and supply of food supplement and Personal care products. Chrysalis develop and supply products to private label and branded clients in UK, Europe, Scandinavia and the Middle East. For full details of the product range and capability visit www.chrysalisweb.com